Ang, JE;
Pandher, R;
Ang, JC;
Asad, YJ;
Henley, A;
Valenti, M;
Box, G;
... Raynaud, FI; + view all
(2016)
Plasma metabolomic changes following PI3K inhibition as pharmacodynamic biomarkers: preclinical discovery to Phase I trial evaluation.
Molecular Cancer Therapeutics
, 15
(6)
pp. 1412-1424.
10.1158/1535-7163.MCT-15-0815.